[DRUG-INDUCED INTERSTITIAL LUNG DISEASE DURING COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LEUPRORELIN ACETATE FOR PROSTATE CANCER].
Nihon Hinyokika Gakkai Zasshi
; 110(1): 36-40, 2019.
Article
em Ja
| MEDLINE
| ID: mdl-31956217
We report a case of drug-induced interstitial lung disease as a result of combined androgen blockade. A 75 year-old male was receiving bicalutamide and reuprorelin acetate treatment for advanced prostate cancer. Two weeks after starting therapy, the patient developed dyspnea due to interstitial lung disease. Based on the clinical diagnosis of drug-induced interstitial lung disease, bicalutamide was withdrawn and steroid therapy was initiated. The patient succumbed 6 days later due to respiratory failure. Drug-induced interstitial lung disease following combined androgen blockade is a rare, but potentially serious adverse effect that requires close attention.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
/
Tipos_de_cancer
/
Prostata
/
Pulmao
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Compostos de Tosil
/
Leuprolida
/
Doenças Pulmonares Intersticiais
/
Antagonistas de Androgênios
/
Anilidas
/
Nitrilas
Limite:
Aged
/
Humans
/
Male
Idioma:
Ja
Revista:
Nihon Hinyokika Gakkai Zasshi
Ano de publicação:
2019
Tipo de documento:
Article